In2Bones SAS has merged with In2Bones USA, its largest distributor, to form i2b, a global company serving the upper and lower extremities orthopaedic markets.
Studies indicate that Rotation Medical’s collagen-based bioinductive implant induced new tissue formation in all 13 patients with partial thickness rotator cuff tears.
Norgine Ventures entered into a definitive agreement to acquire SpineVision. The partnership will support SpineVision’s research and development for commercialization of products combining dynamic stabilization and a minimally invasive, percutaneous approach, such as Flex+2 and LUMIS.
Vexim received approval in Australia to market SpineJack® and the Masterflow™ cement delivery system. Product is slated for initial export within 2016.
Bioretec’s Activa implants, designed for fracture repair, arthrodesis, etc., reached the milestone of 100,000 patients operated over 10 years, with a complication rate of 0.01%.